Attached files

file filename
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - Sanara MedTech Inc.smti_ex211.htm
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Sanara MedTech Inc.smti_ex312.htm
EX-32.2 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - Sanara MedTech Inc.smti_ex322.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Sanara MedTech Inc.smti_ex311.htm
EX-23.1 - CONSENTS OF EXPERTS AND COUNSEL - Sanara MedTech Inc.smti_ex231.htm
EX-10.1.2 - FORM OF RESTRICTED STOCK AWARD AGREEMENT - Sanara MedTech Inc.smti_ex1012.htm
EX-4.1 - DESCRIPTION OF SECURITIES - Sanara MedTech Inc.smti_ex41.htm
EX-3.1 - ARTICLES OF INCORPORATION - Sanara MedTech Inc.smti_ex31.htm
10-K - FORM 10-K - Sanara MedTech Inc.smti_10k.htm
 
EXHIBIT 32.1
 
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
IN ACCORDANCE WITH 18 U.S.C. SECTION 1350,
AS ADOPTED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Annual Report on Form 10-K of Sanara MedTech Inc. (the “Company”) for the period ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof, I, J. Michael Carmena, in my capacity as Principal Executive Officer of the Company and not in my individual capacity, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
 
(1) 
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) 
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in the Report.
 
March 30, 2021
 
/s/ J. Michael Carmena
J. Michael Carmena, Principal Executive Officer